| Product Code: ETC9940438 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Industry Life Cycle |
3.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Porter's Five Forces |
3.5 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Analytical Method, 2021 & 2031F |
3.7 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.8 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing demand for cell and gene therapies in the UK due to increasing prevalence of chronic diseases. |
4.2.2 Technological advancements in cell and gene therapy manufacturing processes leading to higher quality control requirements. |
4.2.3 Supportive regulatory environment and government initiatives to promote cell and gene therapy manufacturing in the UK. |
4.3 Market Restraints |
4.3.1 High costs associated with cell and gene therapy manufacturing quality control processes. |
4.3.2 Limited availability of skilled professionals in the field of quality control for cell and gene therapies. |
5 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Trends |
6 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Types |
6.1 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Equipment & Accessories, 2021- 2031F |
6.1.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Sterility Testing, 2021- 2031F |
6.2.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Purity Testing, 2021- 2031F |
6.2.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Potency Testing, 2021- 2031F |
6.2.5 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Identity Testing, 2021- 2031F |
6.2.6 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Process |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Upstream Processes, 2021- 2031F |
6.3.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Downstream Processes, 2021- 2031F |
6.3.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Process Development, 2021- 2031F |
6.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Contract Manufacturing Organizations, 2021- 2031F |
7 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Export to Major Countries |
7.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Imports from Major Countries |
8 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Key Performance Indicators |
8.1 Percentage of successful cell and gene therapy manufacturing batches passing quality control measures. |
8.2 Number of regulatory approvals received for cell and gene therapy manufacturing processes. |
8.3 Average time taken to complete quality control assessments for cell and gene therapies. |
9 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Opportunity Assessment |
9.1 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Analytical Method, 2021 & 2031F |
9.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Process, 2021 & 2031F |
9.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Competitive Landscape |
10.1 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here